Search Results for agency_names:"Justice Department"

The Bureau of Prisons within the Justice Department has issued a supplemental notice proposing updates to the Inmate Financial Responsibility Program. This program helps inmates manage and pay off financial obligations like court fees and child support while they are incarcerated. The proposal includes changes such as encouraging inmates to pay a portion of outside deposits towards their financial responsibilities, while also prioritizing family support obligations. Public comments on these proposed updates are welcomed until February 18, 2025.

The Department of Justice (DOJ) is seeking public comments for a period of 60 days, ending on April 27, 2021, regarding an information collection under the Radiation Exposure Compensation Act. This proposed extension of a currently approved collection aims to gather data to determine eligibility for compensation. The collection targets individuals or households, requiring an estimated 2.5 hours per respondent, with a total expected annual burden of 5,000 hours. Feedback on the necessity, accuracy, quality, and burden minimization of the collection is requested to enhance its utility and efficiency.

The Department of Justice has lodged a proposed Consent Decree in the lawsuit United States v. Midwest Can Company for violations under the Clean Air Act. The company will have to conduct additional testing on its portable fuel containers and pay a $1.7 million penalty. A public comment period is now open where people can submit feedback on the decree until 30 days after this notice's publication date. The Consent Decree is accessible online and in print for a fee.

The Department of Justice has proposed a legal agreement, known as a consent decree, with US Magnesium LLC and other parties. This agreement aims to resolve violations of environmental laws at a magnesium production facility in Utah. The consent decree calls for significant changes to the facility to reduce its environmental impact, including building a filtration plant and paying a $250,000 penalty. The public can comment on this proposal until 30 days after the notice’s publication.

Globyz Pharma, LLC has applied to the Drug Enforcement Administration (DEA) for registration as an importer of controlled substances for analytical testing. The application does not authorize any other activities, such as importing FDA-approved finished dosage forms for sale. Interested parties, including registered manufacturers, can submit comments or objections, or request a hearing regarding this application by March 26, 2021. The DEA's decision will be based on alignment with legal requirements under 21 U.S.C. 952(a)(2).

The Bureau of Justice Statistics (BJS) of the Department of Justice is submitting a request to the Office of Management and Budget (OMB) to approve a survey about forensic crime laboratories. This survey, called the Census of Publicly Funded Forensic Crime Laboratories (CPFFCL), aims to collect data from state and local government agencies, specifically from 350 crime laboratories, on their staffing, budgets, and challenges. Public comments on the survey can be submitted until March 3, 2025, and participation in the survey is voluntary. The collected data will help provide insight into forensic crime laboratories and will be shared in published reports by the BJS.

On December 9, 2024, the Department of Justice proposed a Consent Decree to settle a lawsuit against Diesel Performance Parts, Inc. for violating the Clean Air Act by selling parts that disable vehicle emission controls. The settlement bans the company and its owner from engaging in activities related to these illegal parts and requires them to destroy remaining inventory, give up related intellectual property, and pay a $320,000 fine. The public can comment on this proposed agreement within 30 days of its announcement. If interested, the full decree is available for review on the Justice Department's website.

Patheon API Services, Inc. has applied to the Drug Enforcement Administration (DEA) to become an importer of certain controlled substances. They intend to use these substances as reference standards in research and development for API Manufacturing, and not for any commercial sales. People affected by this application can submit comments or request a hearing by April 28, 2025. All comments must be submitted electronically through the Federal eRulemaking Portal.

Leading Pharma LLC has applied to register as an importer of controlled substances. This application is for research and development purposes, aiming toward creating a new pharmaceutical product that is pending approval by the Food and Drug Administration (FDA). Interested parties can submit comments or request a hearing regarding this application, with a deadline of January 17, 2025. The Drug Enforcement Administration (DEA) will approve the application only if it meets specific legal criteria.

Organic Standards Solutions International, LLC has applied to the Drug Enforcement Administration (DEA) to register as an importer of certain controlled substances. The company aims to import substances like Marihuana Extract, Marihuana, and a synthetic version of Tetrahydrocannabinols to create analytical reference standards for customers. The public can comment or request a hearing on this application by January 6, 2025, through the Federal eRulemaking Portal. Permits will be approved only if the business activities align with legal requirements, and the company is not authorized to import FDA-approved or non-approved finished products for sale.